<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
    <channel>
        <itunes:owner>
            <itunes:name>KPMG Video Insights</itunes:name>
            <itunes:email>information@kpmg.de</itunes:email>
        </itunes:owner>
        <title>KPMG Video Insights</title>
        <link>https://videostream.kpmg.de</link>
        <description></description>
        <language>de-de</language>
        <generator>Visualplatform</generator>
        <docs>http://blogs.law.harvard.edu/tech/rss</docs>
        <itunes:author>KPMG Video Insights</itunes:author>
        <itunes:subtitle>Unser Podcast für Interessierte</itunes:subtitle>
        <itunes:keywords>Banking</itunes:keywords>
        <itunes:type>episodic</itunes:type>
        <itunes:explicit>no</itunes:explicit>
        <itunes:image href="https://videostream.kpmg.de/files/rv1.36/sitelogo.gif"/>
        <itunes:category text="Business">
            <itunes:category text="Management"/>
        </itunes:category>
        <image>
            <url>https://videostream.kpmg.de/files/rv1.36/sitelogo.gif</url>
            <title>KPMG Video Insights</title>
            <link>https://videostream.kpmg.de</link>
        </image>
        <atom:link rel="self" href="https://videostream.kpmg.de/rss/tag/life sciences companies"/>
        <atom:link rel="next" href="https://videostream.kpmg.de/rss/tag/life sciences companies?tag=life+sciences+companies&amp;p=2&amp;podcast%5fp=f&amp;https="/>
        <item>
            <enclosure url="http://videostream.kpmg.de/64968578/84498186/01888094125b68a4021e44c09d568c7a/video_medium/webcast-navigating-csrd-reporting-video.mp4?source=podcast" type="video/mp4" length="306208427"/>
            <title>Webcast: Navigating CSRD reporting in Life Sciences</title>
            <link>http://videostream.kpmg.de/webcast-navigating-csrd-reporting</link>
            <description>&lt;p&gt;The growing importance of ESG factors, propelled by ESG regulations, will transform sustainability reporting in the Life Sciences industry massively. Companies must consider environmental factors, such as water management, pollution, and circular economy, as well as social factors, such as own workforce, drug development, access to medicine and product safety and integrate them into business models and reporting landscapes.&lt;/p&gt;
&lt;p&gt;In our webcast "Navigating CSRD reporting in Life Sciences" on 14 March from 9:00 to 10:30 am CET, the participants learned from selected industry experts how leading Life Sciences companies are tackling this challenge and how they can successfully prepare themselves for ESG and sustainability reporting.&lt;/p&gt;&lt;p&gt;&lt;a href="http://videostream.kpmg.de/webcast-navigating-csrd-reporting"&gt;&lt;img src="http://videostream.kpmg.de/64968578/84498186/01888094125b68a4021e44c09d568c7a/standard/download-12-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://videostream.kpmg.de/photo/84498186</guid>
            <pubDate>Tue, 14 Mar 2023 14:28:08 GMT</pubDate>
            <media:title>Webcast: Navigating CSRD reporting in Life Sciences</media:title>
            <itunes:summary>The growing importance of ESG factors, propelled by ESG regulations, will transform sustainability reporting in the Life Sciences industry massively. Companies must consider environmental factors, such as water management, pollution, and circular economy, as well as social factors, such as own workforce, drug development, access to medicine and product safety and integrate them into business models and reporting landscapes.
In our webcast "Navigating CSRD reporting in Life Sciences" on 14 March from 9:00 to 10:30 am CET, the participants learned from selected industry experts how leading Life Sciences companies are tackling this challenge and how they can successfully prepare themselves for ESG and sustainability reporting.</itunes:summary>
            <itunes:subtitle>The growing importance of ESG factors, propelled by ESG regulations, will transform sustainability reporting in the Life Sciences industry massively. Companies must consider environmental factors, such as water management, pollution, and circular...</itunes:subtitle>
            <itunes:author>KPMG Video Insights</itunes:author>
            <itunes:duration>01:28:25</itunes:duration>
            <media:description type="html">&lt;p&gt;The growing importance of ESG factors, propelled by ESG regulations, will transform sustainability reporting in the Life Sciences industry massively. Companies must consider environmental factors, such as water management, pollution, and circular economy, as well as social factors, such as own workforce, drug development, access to medicine and product safety and integrate them into business models and reporting landscapes.&lt;/p&gt;
&lt;p&gt;In our webcast "Navigating CSRD reporting in Life Sciences" on 14 March from 9:00 to 10:30 am CET, the participants learned from selected industry experts how leading Life Sciences companies are tackling this challenge and how they can successfully prepare themselves for ESG and sustainability reporting.&lt;/p&gt;&lt;p&gt;&lt;a href="http://videostream.kpmg.de/webcast-navigating-csrd-reporting"&gt;&lt;img src="http://videostream.kpmg.de/64968578/84498186/01888094125b68a4021e44c09d568c7a/standard/download-12-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://videostream.kpmg.de/v.ihtml/player.html?token=01888094125b68a4021e44c09d568c7a&amp;source=podcast&amp;photo%5fid=84498186" width="625" height="352" type="text/html" medium="video" duration="5305" isDefault="true" expression="full"/>
            <media:thumbnail url="http://videostream.kpmg.de/64968578/84498186/01888094125b68a4021e44c09d568c7a/standard/download-12-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://videostream.kpmg.de/64968578/84498186/01888094125b68a4021e44c09d568c7a/standard/download-12-thumbnail.jpg/thumbnail.jpg"/>
            <category>csrd</category>
            <category>esg</category>
            <category>life science industry</category>
            <category>life sciences</category>
            <category>life sciences companies</category>
            <category>webcast</category>
            <category>webcast live</category>
        </item>
        <item>
            <enclosure url="http://videostream.kpmg.de/60650857/64802750/e513203d9e10c067a2f02d898699b3bc/video_medium/tax-implications-for-life-sciences-video.mp4?source=podcast" type="video/mp4" length="6860289"/>
            <title>Tax implications for life sciences companies due to Covid-19</title>
            <link>http://videostream.kpmg.de/tax-implications-for-life-sciences</link>
            <description>&lt;p&gt;&lt;p&gt;In many life sciences companies the corona pandemic has triggered
developments with tax implications: for example, accelerated digitalization and
re-nationalization of supply chains. Our expert Dr. Kai Reusch explains why tax
authorities in many countries are interested in digital business models and how
a relocation of supply chains affects the transfer pricing system and indirect
tax position.&lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://videostream.kpmg.de/tax-implications-for-life-sciences"&gt;&lt;img src="http://videostream.kpmg.de/60650857/64802750/e513203d9e10c067a2f02d898699b3bc/standard/download-12-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://videostream.kpmg.de/photo/64802750</guid>
            <pubDate>Tue, 05 Jan 2021 16:27:24 GMT</pubDate>
            <media:title>Tax implications for life sciences companies due to Covid-19</media:title>
            <itunes:summary>In many life sciences companies the corona pandemic has triggered
developments with tax implications: for example, accelerated digitalization and
re-nationalization of supply chains. Our expert Dr. Kai Reusch explains why tax
authorities in many countries are interested in digital business models and how
a relocation of supply chains affects the transfer pricing system and indirect
tax position.</itunes:summary>
            <itunes:subtitle>In many life sciences companies the corona pandemic has triggered
developments with tax implications: for example, accelerated digitalization and
re-nationalization of supply chains. Our expert Dr. Kai Reusch explains why tax
authorities in many...</itunes:subtitle>
            <itunes:author>KPMG Video Insights</itunes:author>
            <itunes:duration>02:32</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;p&gt;In many life sciences companies the corona pandemic has triggered
developments with tax implications: for example, accelerated digitalization and
re-nationalization of supply chains. Our expert Dr. Kai Reusch explains why tax
authorities in many countries are interested in digital business models and how
a relocation of supply chains affects the transfer pricing system and indirect
tax position.&lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://videostream.kpmg.de/tax-implications-for-life-sciences"&gt;&lt;img src="http://videostream.kpmg.de/60650857/64802750/e513203d9e10c067a2f02d898699b3bc/standard/download-12-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://videostream.kpmg.de/v.ihtml/player.html?token=e513203d9e10c067a2f02d898699b3bc&amp;source=podcast&amp;photo%5fid=64802750" width="625" height="352" type="text/html" medium="video" duration="152" isDefault="true" expression="full"/>
            <media:thumbnail url="http://videostream.kpmg.de/60650857/64802750/e513203d9e10c067a2f02d898699b3bc/standard/download-12-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://videostream.kpmg.de/60650857/64802750/e513203d9e10c067a2f02d898699b3bc/standard/download-12-thumbnail.jpg/thumbnail.jpg"/>
            <category>corona</category>
            <category>customs</category>
            <category>digital business models</category>
            <category>digitalization</category>
            <category>digital services taxes</category>
            <category>english</category>
            <category>input VAT</category>
            <category>life science industry</category>
            <category>life sciences companies</category>
            <category>pandemic</category>
            <category>pharmacenticals</category>
            <category>principal models</category>
            <category>supply chain</category>
            <category>tax</category>
            <category>tax authorities</category>
            <category>tax law</category>
            <category>transfer pricing</category>
            <category>VAT</category>
        </item>
        <item>
            <enclosure url="http://videostream.kpmg.de/60445192/64802811/54343ba0ddf822e6e820c3c61241e9f1/video_medium/cyber-security-and-life-sciences-video.mp4?source=podcast" type="video/mp4" length="6236358"/>
            <title>Cyber Security and life sciences companies: new threats from Covid-19</title>
            <link>http://videostream.kpmg.de/cyber-security-and-life-sciences</link>
            <description>&lt;p&gt;&lt;p&gt;The corona crisis
and its associated measures have accelerated digitization in many companies – including life sciences companies. This has led to new attack scenarios for
cybercrime. Even if there is no such thing as 100 percent security, as our
expert Marko Vogel says, companies can do a lot to protect themselves against
cyberattacks. Marko Vogel explains in the video which activities companies have
to address in this context and which considerations they should take into
account when it comes to cyber security.&lt;/p&gt;&lt;br&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://videostream.kpmg.de/cyber-security-and-life-sciences"&gt;&lt;img src="http://videostream.kpmg.de/60445192/64802811/54343ba0ddf822e6e820c3c61241e9f1/standard/download-12-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://videostream.kpmg.de/photo/64802811</guid>
            <pubDate>Tue, 05 Jan 2021 16:09:23 GMT</pubDate>
            <media:title>Cyber Security and life sciences companies: new threats from Covid-19</media:title>
            <itunes:summary>The corona crisis
and its associated measures have accelerated digitization in many companies – including life sciences companies. This has led to new attack scenarios for
cybercrime. Even if there is no such thing as 100 percent security, as our
expert Marko Vogel says, companies can do a lot to protect themselves against
cyberattacks. Marko Vogel explains in the video which activities companies have
to address in this context and which considerations they should take into
account when it comes to cyber security.</itunes:summary>
            <itunes:subtitle>The corona crisis
and its associated measures have accelerated digitization in many companies – including life sciences companies. This has led to new attack scenarios for
cybercrime. Even if there is no such thing as 100 percent security, as our...</itunes:subtitle>
            <itunes:author>KPMG Video Insights</itunes:author>
            <itunes:duration>02:24</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;p&gt;The corona crisis
and its associated measures have accelerated digitization in many companies – including life sciences companies. This has led to new attack scenarios for
cybercrime. Even if there is no such thing as 100 percent security, as our
expert Marko Vogel says, companies can do a lot to protect themselves against
cyberattacks. Marko Vogel explains in the video which activities companies have
to address in this context and which considerations they should take into
account when it comes to cyber security.&lt;/p&gt;&lt;br&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://videostream.kpmg.de/cyber-security-and-life-sciences"&gt;&lt;img src="http://videostream.kpmg.de/60445192/64802811/54343ba0ddf822e6e820c3c61241e9f1/standard/download-12-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://videostream.kpmg.de/v.ihtml/player.html?token=54343ba0ddf822e6e820c3c61241e9f1&amp;source=podcast&amp;photo%5fid=64802811" width="625" height="352" type="text/html" medium="video" duration="144" isDefault="true" expression="full"/>
            <media:thumbnail url="http://videostream.kpmg.de/60445192/64802811/54343ba0ddf822e6e820c3c61241e9f1/standard/download-12-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://videostream.kpmg.de/60445192/64802811/54343ba0ddf822e6e820c3c61241e9f1/standard/download-12-thumbnail.jpg/thumbnail.jpg"/>
            <category>Absicherung gegen Cyber-Risiken</category>
            <category>artificial intelligence</category>
            <category>cloud</category>
            <category>cyber attacks</category>
            <category>cybercrime</category>
            <category>cyber security</category>
            <category>data</category>
            <category>data protection</category>
            <category>digitalization</category>
            <category>english</category>
            <category>IT</category>
            <category>IT organisation</category>
            <category>IT security</category>
            <category>life sciences companies</category>
            <category>nano technology</category>
            <category>security by design</category>
            <category>value chain</category>
        </item>
    </channel>
</rss>
